These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15464445)

  • 21. Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models.
    Song Y; Sonawane ND; Salinas D; Qian L; Pedemonte N; Galietta LJ; Verkman AS
    J Biol Chem; 2004 Sep; 279(39):40629-33. PubMed ID: 15280357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finally, mice with CF lung disease.
    Frizzell RA; Pilewski JM
    Nat Med; 2004 May; 10(5):452-4. PubMed ID: 15122239
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
    Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can curcumin cure cystic fibrosis?
    Zeitlin P
    N Engl J Med; 2004 Aug; 351(6):606-8. PubMed ID: 15295056
    [No Abstract]   [Full Text] [Related]  

  • 27. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin.
    Cartiera MS; Ferreira EC; Caputo C; Egan ME; Caplan MJ; Saltzman WM
    Mol Pharm; 2010 Feb; 7(1):86-93. PubMed ID: 19886674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
    Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).
    Storm K; Moens E; Vits L; De Vlieger H; Delaere G; D'Hollander M; Wuyts W; Biervliet M; Van Schil L; Desager K; Nöthen MM
    J Cyst Fibros; 2007 Nov; 6(6):371-5. PubMed ID: 17481968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New therapeutic approaches to Cystic fibrosis].
    Willemot JM; Sermet Gaudelus I; Lenoir G
    Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs.
    Knorre A; Wagner M; Schaefer HE; Colledge WH; Pahl HL
    Biol Chem; 2002 Feb; 383(2):271-82. PubMed ID: 11934265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between inhibitory ferric and stimulatory curcumin regulates phosphorylation-dependent human cystic fibrosis transmembrane conductance regulator and ΔF508 activity.
    Wang G
    Biochemistry; 2015 Feb; 54(7):1558-66. PubMed ID: 25635662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
    Jouret F; Bernard A; Hermans C; Dom G; Terryn S; Leal T; Lebecque P; Cassiman JJ; Scholte BJ; de Jonge HR; Courtoy PJ; Devuyst O
    J Am Soc Nephrol; 2007 Mar; 18(3):707-18. PubMed ID: 17287432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
    Wang Y; Bartlett MC; Loo TW; Clarke DM
    Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Preumont V; Hermans MP; Lebecque P; Buysschaert M
    Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
    Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
    Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal phenotype of variable-weight cystic fibrosis knockout mice.
    Canale-Zambrano JC; Poffenberger MC; Cory SM; Humes DG; Haston CK
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G222-9. PubMed ID: 17615178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
    Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
    Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.